These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26585846)

  • 1. Afatinib-induced hypertrichosis of the eyelashes and eyebrows.
    Miguel-Gomez L; Vano-Galvan S; Garrido-Lopez P; Jaen-Olasolo P
    Indian J Dermatol Venereol Leprol; 2016; 82(2):192-3. PubMed ID: 26585846
    [No Abstract]   [Full Text] [Related]  

  • 2. Trichomegaly secondary to erlotinib.
    Desai RU; Rachakonda LP; Saffra NA
    Can J Ophthalmol; 2009 Dec; 44(6):e65. PubMed ID: 20052001
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired trichomegaly: trichomegaly secondary to erlotinib.
    Medina Mendez CA; Ma PC; Singh AD
    JAMA Ophthalmol; 2014 Sep; 132(9):1051. PubMed ID: 25078467
    [No Abstract]   [Full Text] [Related]  

  • 4. Erlotinib-induced trichomegaly in a male patient with pancreatic cancer.
    Saif MW; Gnanaraj J
    Cutan Ocul Toxicol; 2010 Mar; 29(1):62-6. PubMed ID: 19954400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva).
    Márquez G; Herrera-Acosta E; Vidal I; Galvany L; Iglesias M; Umbert P
    Int J Dermatol; 2009 Jan; 48(1):97-8. PubMed ID: 19126063
    [No Abstract]   [Full Text] [Related]  

  • 6. Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib.
    Braiteh F; Kurzrock R; Johnson FM
    J Clin Oncol; 2008 Jul; 26(20):3460-2. PubMed ID: 18612164
    [No Abstract]   [Full Text] [Related]  

  • 7. Trichomegaly induced by erlotinib.
    Papadopoulos R; Chasapi V; Bachariou A
    Orbit; 2008; 27(4):329-30. PubMed ID: 18716976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acquired trichomegaly and hypertrichosis].
    Aerts L; Lauwers N; Smets RM
    J Fr Ophtalmol; 2014 Apr; 37(4):339-41. PubMed ID: 24576565
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: case reports and a review of literature.
    Zhang G; Basti S; Jampol LM
    Cornea; 2007 Aug; 26(7):858-60. PubMed ID: 17667622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib.
    Vergou T; Stratigos AJ; Karapanagiotou EM; Matekovits AE; Dilana KD; Tsimboukis S; Antoniou C; Chasapi V; Syrigos KN
    J Am Acad Dermatol; 2010 Aug; 63(2):e56-8. PubMed ID: 20633793
    [No Abstract]   [Full Text] [Related]  

  • 11. Trichomegaly of the eyelashes after colorectal cancer treatment with the epidermal growth factor receptor inhibitor cetuximab.
    Bambury R; McCaffrey JA
    Clin Colorectal Cancer; 2009 Oct; 8(4):235. PubMed ID: 19822516
    [No Abstract]   [Full Text] [Related]  

  • 12. Erlotinib-associated trichomegaly.
    Lane K; Goldstein SM
    Ophthalmic Plast Reconstr Surg; 2007; 23(1):65-6. PubMed ID: 17237698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eyelash and eyebrow trichomegaly induced by interferon-alfa 2a.
    Goksugur N; Karabay O
    Clin Exp Dermatol; 2007 Sep; 32(5):583-4. PubMed ID: 17509059
    [No Abstract]   [Full Text] [Related]  

  • 14. Loss of Eyebrows and Eyelashes During Concomitant Treatment with Sitagliptin and Metformin.
    Succurro E; Palleria C; Ruffo M; Serra R; Arturi F; Gallelli L
    Curr Drug Saf; 2017; 12(1):10-12. PubMed ID: 27758711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.
    Rodriguez NA; Ascaso FJ
    J Clin Oncol; 2011 Jun; 29(18):e532-3. PubMed ID: 21483009
    [No Abstract]   [Full Text] [Related]  

  • 16. Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost.
    Herane MI; Urbina F
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):644-5. PubMed ID: 15324422
    [No Abstract]   [Full Text] [Related]  

  • 17. Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody).
    Foerster CG; Cursiefen C; Kruse FE
    Cornea; 2008 Jun; 27(5):612-4. PubMed ID: 18520515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular side effects and trichomegaly of eyelashes induced by erlotinib: a case report and review of the literature.
    Celik T; Kosker M
    Cont Lens Anterior Eye; 2015 Feb; 38(1):59-60. PubMed ID: 25249292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost.
    Johnstone MA
    Am J Ophthalmol; 1997 Oct; 124(4):544-7. PubMed ID: 9323945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excessive growth of eyelashes in patients with acquired immunodeficiency syndrome.
    Baccard M; Morel P
    Cutis; 1994 Feb; 53(2):83-4. PubMed ID: 7851127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.